Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Friday, December 1, 2006

Smokers may be 12 times more resistant to the effects of aspirin. Researchers recently published the findings of a study designed to determine which factors predicted a poor response to aspirin. One third of the 123 subjects were smokers. Patients were evaluated based on the dose of aspirin they were taking. Eight of the 66 patients taking low-dose (81 mg) aspirin were found to be resistant to its effects. When the dose was increased to 325 mg, only one patient remained resistant. In the group that took 325 mg, 3 were resistant. Adding a dose of clopidogrel resulted in a response in 2 of these 3 patients.

The authors concluded that smoking may contribute to aspirin resistance. This finding further reinforces the need for smoking cessation.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues